NCT05181956 is a clinical trial in Chronic Hepatitis D Infection With Hepatitis B, sponsored by Asian Pacific Liver Center at Coalition of Inclusive Medicine.

Who is sponsoring NCT05181956?

NCT05181956 is sponsored by Asian Pacific Liver Center at Coalition of Inclusive Medicine.

What condition does NCT05181956 study?

NCT05181956 studies Chronic Hepatitis D Infection With Hepatitis B.

Is NCT05181956 still recruiting?

NCT05181956 is currently status unknown. Last updated 10 January 2022.

Last reviewed 2022-01-10 · How we verify

NCT05181956

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testing and Epidemiology of Delta Hepatitis

Status unknown Last updated 10 January 2022

What this trial tests

trial in Chronic Hepatitis D Infection With Hepatitis B in 5,000 participants. Status unknown.

Timeline

3 January 2022

Primary endpoint
31 December 2022

31 March 2023

Quick facts

Lead sponsor	Asian Pacific Liver Center at Coalition of Inclusive Medicine
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	5,000
Start date	3 January 2022
Primary completion	31 December 2022
Estimated completion	31 March 2023
Sites	1 location across United States

Conditions studied

Chronic Hepatitis D Infection With Hepatitis B — all drugs for Chronic Hepatitis D Infection With Hepatitis B →

Sponsor

Asian Pacific Liver Center at Coalition of Inclusive Medicine

Who can join

18 and older, any sex, with Chronic Hepatitis D Infection With Hepatitis B. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study is to 1. Understand the pattern of hepatitis delta screening among medical providers for Asian patients with chronic hepatitis B 2. Determine the proportion of Asian hepatitis B patients who have been screened and who have chronic hepatitis delta 3. Determine the pattern of hepatitis delta screening after education of medical providers on hepatitis delta

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Asian Pacific Liver Center at Coalition of Inclusive Medicine trials

Trials by the same sponsor.

NCT02957994 — TAF Switch Study in Hepatitis B Monoinfection · Phase 4 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05181956 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asian Pacific Liver Center at Coalition of Inclusive Medicine
Last refreshed: 10 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05181956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing